Bioremediation Related News

Intrexon Responds to Short-Sellers’ Report

Holders of Intrexon Corporation stock are watching their portfolios carefully in wake of the anonymous publication last Thursday of a short-seller report that alleges the company’s technology is less cutting-edge than it claims and that its revenues are exaggerated. On [...]

Harvest Capital Strategies Raises $245M Fund for Companies Utilizing Tools of Intrexon

Harvest Capital Strategies announced Tuesday that it has raised $245 million to specifically finance companies utilizing the synthetic biology tools of Intrexon Corporation. This is big news for Intrexon, whose subsidiaries and their genetically modified products have been prominent in [...]

From BIOtech to bioTECH: Meet Serial Entrepreneur Randal Kirk, CEO of Intrexon

There will be a lot of synthetic biologists at the upcoming conference, and a lot of entrepreneurs hoping to scale their company to greatness and riches (often these two are combined into the same person). It is, however, a difficult [...]

Intrexon Stock Offering Generates $230 Million

The synthetic biology company Intrexon Corporation recently announced the closing of its public stock offering, which garnered $230 million dollars from the sale of more than 5.5 million shares in the course of a week. This is just the latest [...]